Incyte (INCY) Reports Q1 Loss of $2.86, Reaffirms Guidance
Go back to Incyte (INCY) Reports Q1 Loss of $2.86, Reaffirms Guidance| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 97.98 +5.74 (6.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.24 | 52 Week High | $118.49 | |||
| Open | $93.02 | 52 Week Low | $55.00 | |||
| Day High | $98.48 | P/E | N/A | |||
| Day Low | $92.66 | EPS | $-0.56 | |||
| Volume | 2,269,985 | |||||
